Ryan Allway January 25th, 2019 News, Top Story The global cannabis industry is projected to reach more than $150 billion by 2025, according to Grand View Research, driven by legalization across a growing number of countries. While most investors are focused on cannabis cultivators and retailers, these companies still... Read more
Ryan Allway January 24th, 2019 VANCOUVER, British Columbia, and SEATTLE, Jan. 24, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the testing of cannabinoids in human subjects for its immune stimulatory program in cancer. Furthermore, the Company... Read more
Ryan Allway January 23rd, 2019 Exclusive, Top News, Uncategorized Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of adult-use cannabis in October of last year. While many licensed producers have been scaling up their production, the... Read more
Producing Supreme Cannabis At Scale
January 22, 2019
Ryan Allway January 22nd, 2019 Exclusive, News Canada’s cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of recreational cannabis last year. While many licensed producers are ramping up capacity, investors may want to shift their focus to... Read more
Ryan Allway January 16th, 2019 Uncategorized The cannabis industry experienced significant growth last year, particularly in Canada following the legalization of adult-use cannabis on a federal level. The upcoming legalization of edible products across Canada could open the door to further growth in 2019 and beyond. Health Canada also... Read more
Exclusive Interview: Lexaria CEO Discusses Progress & Plans at O’Cannabiz 2018
Uncategorized January 8, 2019
Ryan Allway January 8th, 2019 Uncategorized The O’Cannabiz Conference and Expo in Vancouver, Canada last month featured hundreds of cannabis companies from around the world this year—and CFN Media was there to film exclusive interviews with many of the leaders in the space. Lexaria Biosciences Inc. (CSE: LXX) (OTCQX:... Read more
NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Proprietary Technology Transforms the Way Molecules Enter the Body
January 8, 2019
Biotechnology company Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) revolutionary technology, DehydraTECH, alters the way that fat soluble, plant-derived molecules are absorbed into the body. A recent article further discussing the company reads, “Chemicals or intimidating complex ingredients that require disclosure on food labels are not required additions when using... Read more
Canntab & FSD Pharma Make Cannabis More Palatable for Doctors
Uncategorized December 20, 2018
Ryan Allway December 20th, 2018 Uncategorized Cannabinoids have the potential to radically transform the pharmaceutical industry. For example, new studies suggest that cannabis legalization could reduce opioid prescriptions by about six to 12 percent. The problem is that medical cannabis is very different from pharmaceutical drugs—it’s hard for... Read more
Pascal Biosciences Provides Year-End Investor Update and Reviews Upcoming Milestones
December 20, 2018
Ryan Allway December 20th, 2018 – 2018 pipeline expansion includes lead cannabinoid-based cancer therapeutic– Clinical trial in glioblastoma to begin in 2019 VANCOUVER, British Columbia and SEATTLE, Dec. 20, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced... Read more
How California Can Overcome Its Cannabis Challenges
CaliforniaUncategorized December 14, 2018
Ryan Allway December 14th, 2018 Uncategorized California’s cannabis industry is projected to reach $5.1 billion by the end of 2019, according to BDS Analytics, but unexpected challenges have slowed progress. These challenges range from excessive regulations to sky-high taxation. Investors looking for opportunities in the state may want... Read more
